We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAdalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open-label study.AuthorsPeyrin-Biroulet, L; Laclotte, C; Bigard, M-AAbstractAdalimumab is effective in inducing remission in patients with active Crohn's disease who had secondary failure to infliximab therapy.PublicationAlimentary pharmacology & therapeutics, 2007, Vol 25, Issue 6, p675ISSN0269-2813Publication typeJournal ArticleDOI10.1111/j.1365-2036.2007.03254.x